Dermatology Market Update 2026: Second Bites, Regulatory Headwinds, and the Flight Toward Scale

PGP’s CEO Michael Kroin published an article in Dermatology Times providing an update on the state of private equity investment in dermatology heading into 2026.

The Key Takeaways from the article:

  • Private equity groups are re-entering dermatology, focusing on clinical excellence and long-term stability, while navigating regulatory challenges in restrictive states.
  • Larger, infrastructure-rich platforms are prioritized, with buyers favoring practices with revenue scale, multi-site density, and integrated ancillary services.
  • Smaller dermatology groups must demonstrate growth potential or join existing platforms to attract investor interest.
  • Dermatology remains a dynamic specialty, offering opportunities and challenges for practice owners navigating strategic decisions.

Read the Full Article Here

PGP Advises Garden OB/GYN in its Strategic Affiliation with Northwell Health